N/A N=410 Description of the Population With Genitourinary Tumors and COVID-19
Covid19 · Genito Urinary Cancer
Primary: Age at Baseline — 70 years
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=24 Therapeutic Effects of Topical Herbal Medicine -Rhubarb Ointment on Rosacea
Rosacea · Chinese Herbal Medicine
Primary: Reduction of Flushing, Erythema, Telangiectasia, Papules, and Pustules — 1; 1.92 score on a scale
Phase 4 N=44 Study Using CABENUVA™ for the Treatment of Human Immunodeficiency Virus (HIV)-1, Administered in Infusion Centers (IC) or Alternate Sites of Administration (ASA) in the United States (U.S.)
HIV Infections
Primary: Number of Participants Who Agree or Completely Agree (a Score of 4 or Higher) Across All Items on the Feasibility of Intervention Measure (FIM) — 31 Participants
N/A N=2,521 Cannabis Edibles Packaging Descriptors Experiment
Cannabis Use
Primary: Product Appeal — 6.43; 6.04; 6.04; 6.06 score on a scale 0-10
Phase 2 N=11 Study to Evaluate the Safety and Efficacy of SPR001 in Subjects With Classic Congenital Adrenal Hyperplasia
Congenital Adrenal Hyperplasia · CAH - Congenital Adrenal Hyperplasia · CAH - 21-Hydroxylase Deficiency
Primary: The Incidence of Treatment-emergent Adverse Events (Safety and Tolerability) in Subjects With CAH — 9; 2 Participants
Early Phase 1 N=11 Transgender Estradiol
Transgender Persons
Primary: Maximum Serum Concentration of Estradiol — 144; 35 pg/mL
N/A N=12 Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care
Cirrhosis, Liver
Primary: Hepatocellular Carcinoma Screening — 1.61 Odds ratio
N/A N=956 Building and Sustaining Interventions for Children: Task-sharing Mental Health Care in Low-resource Settings
Grief · Post Traumatic Stress Disorder · Depression
Primary: Change in Posttraumatic Stress Symptoms (Child Report) — -13.2; -12.8; -6.9 score on a scale
Phase 2 N=9 Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer · KRAS Mutation-Related Tumors
Primary: Objective Response Rate — 9 Participants
N/A N=79 A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread
Urothelial Carcinoma
Primary: Age of Participants at Baseline — 72 Years
N/A N=110 Testing the Effect of the Youth Mindful Awareness Program on Negative Affect
Mindfulness
Primary: Momentary Negative Affect Assessed With Ecological Momentary Assessment — -.17; .14 score on a scale — p=.048
Phase 2 N=80 Speech Entrainment for Aphasia Recovery
Aphasia · Aphasia Non Fluent · Stroke
Primary: Average Verbs Per Minute (VPM) Change From Baseline — 0.3; 0.62; -0.26; 0.52 verbs per minute
N/A N=1,146 NUDGE-EHR Replication Trial at Mass General Brigham
Aging · Benzodiazepine Sedative Adverse Reaction · Anticholinergic Adverse Reaction
Primary: Change in Inappropriate Prescribing — 106; 145; 122 Participants — p=0.002
Phase 1 N=73 First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4011499 in Healthy Participants
HIV Infections
Primary: Part 1: Number of Participants With Adverse Events (AEs) — 3; 2; 1; 3 Participants
N/A N=23 Assessment of New Enhanced Ostomy Device in Real-life Settings in Subjects Having a Stoma
Ileostomy - Stoma · Colostomy Stoma
Primary: Trans Epidermal Water Loss — 39.0; 35.9 g/m^2/h